UCB9608
UCB9608 is a potent, selective and orally active PI4KIIIβ inhibitor, with an IC50 of 11 nM, selective over PI3KC2 α, β, and γ lipid kinases. UCB9608 improves metabolic stability and exhibits excellent pharmacokinetic profile, acts as a potent immunosuppressive agent[1].
Product Specifications
CAS Number
1616413-96-7
UNSPSC
12352005
Hazard Statement
H302
Target
PI4K
Type
Reference compound
Related Pathways
PI3K/Akt/mTOR
Applications
COVID-19-immunoregulation
Field of Research
Inflammation/Immunology
Assay Protocol
https://www.medchemexpress.com/UCB9608.html
Concentration
10mM
Purity
99.59
Solubility
DMSO : 65 mg/mL (ultrasonic)
Smiles
NC1=NC(N2CCN(C(NC3=CC=C(OC)C=C3C)=O)C[C@@H]2C)=C4C(N(C)N=C4)=N1
Molecular Formula
C20H26N8O2
Molecular Weight
410.47
Precautions
H302
References & Citations
[1]Reuberson J, et al. Discovery of a Potent, Orally Bioavailable PI4KIIIβ Inhibitor (UCB9608) Able To Significantly Prolong Allogeneic Organ Engraftment in Vivo. J Med Chem. 2018 Aug 9;61 (15) :6705-6723.
Shipping Conditions
Room Temperature
Storage Conditions
-20°C, 3 years; 4°C, 2 years (Powder)
Scientific Category
Reference compound1
Clinical Information
No Development Reported
Available Sizes
Frequently Asked Questions
More Discoveries
Explore Other Products
Browse additional items from our catalog
BNC742309-100 1x 100 µL
NKX2.2 (Neuroendocrine & Ewing s Sarcoma Marker) (rNX2/1523), CF740 conjugate, 0.1mg/mL
Sign In for Pricing
View Details 
E-EL-H1007-01 24 Tests
Human βTG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) ELISA Kit
Sign In for Pricing
View Details E-EL-H1007-02 48 Tests
Human βTG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) ELISA Kit
Sign In for Pricing
View Details E-EL-H1007-03 96 Tests
Human βTG/PBP/CXCL7/NAP2 (Thromboglobulin, Beta) ELISA Kit
Sign In for Pricing
View Details 
